Literature DB >> 14702185

Angiogenic factors and the endometrium following long term progestin only contraception.

C J Lockwood1, F Schatz, G Krikun.   

Abstract

Endometria from long term progestin only contraceptive-treated patients display abnormally enlarged blood vessels that are prone to bleeding as well as inflammation and possibly local diminution in blood flow. Such bleeding is also characterized by focal reductions in the expression of angiopoietin-1, a vessel stabilization and maturation agent, and excess production of the potent angiogenic agents, vascular endothelial growth factor and angiopoietin-2. In addition, tissue factor, the key initiator of hemostasis may play an angiogenic role either directly or via the activation of thrombin. This review article summarizes current findings related to the endometrial dysregulation of angiogenic/hemostatic agents following treatment with long term progestin only contraception. Studies in this area offer a promising avenue to alleviate abnormal uterine bleeding associated with this otherwise highly effective form of contraception

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14702185     DOI: 10.14670/HH-19.167

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

2.  Long-acting progestin-only contraceptives impair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival.

Authors:  Umit A Kayisli; Murat Basar; Ozlem Guzeloglu-Kayisli; Nihan Semerci; Helen C Atkinson; John Shapiro; Taryn Summerfield; S Joseph Huang; Katja Prelle; Frederick Schatz; Charles J Lockwood
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

3.  Effects of etonogestrel treatment in the reproductive organs and uterine arteries of nonoophorectomized guinea pigs.

Authors:  Graciela Krikun; C J Booth; L Buchwalder; F Schatz; G Osol; Maurizio Mandala; C J Lockwood
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

Review 4.  Iatrogenic unscheduled (breakthrough) endometrial bleeding.

Authors:  M Hickey; I S Fraser
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

5.  Long-term progestin contraceptives (LTPOC) induce aberrant angiogenesis, oxidative stress and apoptosis in the guinea pig uterus: A model for abnormal uterine bleeding in humans.

Authors:  Graciela Krikun; Irina A Buhimschi; Martha Hickey; Frederick Schatz; Lynn Buchwalder; Charles J Lockwood
Journal:  J Angiogenes Res       Date:  2010-04-27

6.  Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.

Authors:  Ozlem Guzeloglu Kayisli; Umit A Kayisli; Murat Basar; Nihan Semerci; Frederick Schatz; Charles J Lockwood
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

7.  Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells.

Authors:  Sefa Arlıer; Ümit Ali Kayışlı; Aydın Arıcı
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29

8.  In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis.

Authors:  Sara Santorelli; Deborah P Fischer; Michael K Harte; Johanna Laru; Kay M Marshall
Journal:  Pharmacol Res Perspect       Date:  2021-04

9.  Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.

Authors:  Maofeng Wang; Junqing Chen; Jun Ying; Jiong Yu; Bifei Huang; Zhaoxiang Ren; Xianyu Wang; Qiaoqiao Guo; Yunlai Wang; Liuyi Qiu; Hongsheng Yu; Rugen Wan
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.